Increased levels of serum IgM antibody to staphylococcal enterotoxin B in patients with rheumatoid arthritis. 1995

T Origuchi, and K Eguchi, and Y Kawabe, and I Yamashita, and A Mizokami, and H Ida, and S Nagataki
First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.

OBJECTIVE To investigate the role of superantigen in rheumatoid arthritis (RA) by assaying the serum levels of staphylococcal enterotoxin B (SEB) antibodies. METHODS Serum IgG and IgM SEB antibodies were measured using an enzyme linked immunosorbent assay (ELISA), and confirmed by Western blot analysis. The T cell receptor V beta (TCR V beta) repertoire was analysed using the reverse transcriptase polymerase chain reaction. RESULTS RA patients had increased levels of serum IgM SEB antibody compared with normal subjects, patients with systemic lupus erythematosus, Sjögren's syndrome, and Behçet's disease. The titres of rheumatoid factor (RF) showed no correlation with the levels of IgM SEB antibodies, and the levels of SEB antibodies were not inhibited by the addition of human immunoglobulin, or after absorption of RF. RA patients whose disease duration was less than 10 years had greater levels of serum IgM SEB antibodies than those with disease duration more than 10 years. The levels of IgM and IgG SEB antibodies in synovial fluid from RA patients were correlated with those in their sera. Western blot analysis detected IgM and IgG SEB antibodies as a band of approximately 30 kDa molecular size. The percentage of TCR V beta 2, V beta 5.2, and V beta 12 in phytohaemagglutinin stimulated peripheral T cells correlated significantly with the levels of serum IgM SEB antibody in RA patients. CONCLUSIONS These results suggest that SEB, one of the superantigens, may have a critical role in the pathogenesis of RA.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004768 Enterotoxins Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria. Staphylococcal Enterotoxin,Enterotoxin,Staphylococcal Enterotoxins,Enterotoxin, Staphylococcal,Enterotoxins, Staphylococcal
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T Origuchi, and K Eguchi, and Y Kawabe, and I Yamashita, and A Mizokami, and H Ida, and S Nagataki
October 2014, Iranian Red Crescent medical journal,
T Origuchi, and K Eguchi, and Y Kawabe, and I Yamashita, and A Mizokami, and H Ida, and S Nagataki
August 2015, International journal of dermatology,
T Origuchi, and K Eguchi, and Y Kawabe, and I Yamashita, and A Mizokami, and H Ida, and S Nagataki
December 2005, International archives of allergy and immunology,
T Origuchi, and K Eguchi, and Y Kawabe, and I Yamashita, and A Mizokami, and H Ida, and S Nagataki
November 2014, Life sciences,
T Origuchi, and K Eguchi, and Y Kawabe, and I Yamashita, and A Mizokami, and H Ida, and S Nagataki
September 2016, International journal of molecular sciences,
T Origuchi, and K Eguchi, and Y Kawabe, and I Yamashita, and A Mizokami, and H Ida, and S Nagataki
September 1968, Annals of the rheumatic diseases,
T Origuchi, and K Eguchi, and Y Kawabe, and I Yamashita, and A Mizokami, and H Ida, and S Nagataki
January 1976, Scandinavian journal of rheumatology,
T Origuchi, and K Eguchi, and Y Kawabe, and I Yamashita, and A Mizokami, and H Ida, and S Nagataki
January 2016, Clinical and experimental rheumatology,
T Origuchi, and K Eguchi, and Y Kawabe, and I Yamashita, and A Mizokami, and H Ida, and S Nagataki
June 2005, Infection and immunity,
T Origuchi, and K Eguchi, and Y Kawabe, and I Yamashita, and A Mizokami, and H Ida, and S Nagataki
September 1995, Scandinavian journal of immunology,
Copied contents to your clipboard!